United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 372.89 USD 1.51% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

Relative Value

The Relative Value of one UTHR stock under the Base Case scenario is 291.69 USD. Compared to the current market price of 372.89 USD, United Therapeutics Corp is Overvalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

UTHR Relative Value
Base Case
291.69 USD
Overvaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
12
vs Industry
59
Median 3Y
5.3
Median 5Y
5.1
Industry
7.7
Forward
5.7
vs History
38
vs Industry
9
Median 3Y
14.4
Median 5Y
13.5
Industry
22.7
Forward
14.9
vs History
17
vs Industry
10
Median 3Y
12.8
Median 5Y
11.9
Industry
21.6
vs History
1
vs Industry
6
Median 3Y
17.6
Median 5Y
16.1
Industry
25.2
vs History
4
vs Industry
33
Median 3Y
2.2
Median 5Y
2.1
Industry
2.5
vs History
23
vs Industry
54
Median 3Y
4.4
Median 5Y
4.2
Industry
7.7
Forward
4.5
vs History
17
vs Industry
53
Median 3Y
4.9
Median 5Y
4.6
Industry
9
vs History
34
vs Industry
10
Median 3Y
8.5
Median 5Y
8.2
Industry
4.2
Forward
8.8
vs History
34
vs Industry
9
Median 3Y
8.9
Median 5Y
8.8
Industry
4.1
Forward
9.4
vs History
25
vs Industry
11
Median 3Y
10.6
Median 5Y
9.8
Industry
5.7
vs History
17
vs Industry
8
Median 3Y
13.3
Median 5Y
12.2
Industry
3.6
vs History
3
vs Industry
37
Median 3Y
2.6
Median 5Y
2.5
Industry
4.6

Multiples Across Competitors

UTHR Competitors Multiples
United Therapeutics Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
United Therapeutics Corp
NASDAQ:UTHR
16.6B USD 6 15 9.4 9.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
US
United Therapeutics Corp
NASDAQ:UTHR
Average P/E: 176.1
15
29%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
United Therapeutics Corp
NASDAQ:UTHR
Average EV/EBITDA: 16.1
9.4
32%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
United Therapeutics Corp
NASDAQ:UTHR
Average EV/EBIT: 20.7
9.9
37%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top